Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 1, 2016
Event: Regulation FD Disclosure regarding the preparation and intended use of presentation materials for the Marcum Microcap Conference (June 1-2, 2016) and other investor communications.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of presentation materials and does not contain financial statements or quantitative performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing discloses the availability of summary presentation materials intended for use in investor relations activities.
Guidance, Outlook, and Risks
- Management Commentary: The presentation materials contain summary information and speak as of June 1, 2016.
- Forward-Looking Disclaimers: The Company specifically disclaims any obligation to update the presentation materials to reflect future events or circumstances.
- Legal Status: Information furnished under Item 7.01 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Presentation Materials) for specific business updates not detailed in the 8-K text.
- Verify the most recent audited financial statements in the Company's latest 10-K or 10-Q filings, as this 8-K contains no financial data.
- Confirm the Company's current status on the Investor Relations section of www.biorestorative.com, where the materials are posted for 90 days.